ZA991946B - Pyrazolopyrimidines and pyrazolotriazines. - Google Patents

Pyrazolopyrimidines and pyrazolotriazines.

Info

Publication number: ZA991946B
Authority: ZA; South Africa
Prior art keywords: pyrazolotriazines; pyrazolopyrimidines
Prior art date: 1998-03-11

Application number

ZA9901946A

Other languages

English (en)

Inventor

Michael Boes

Claus Riemer

Heinz Stadler

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-03-11

Filing date

1999-03-10

Publication date

1999-09-13

1999-03-10 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1999-09-13 Publication of ZA991946B publication Critical patent/ZA991946B/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Psychiatry (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

ZA9901946A 1998-03-11 1999-03-10 Pyrazolopyrimidines and pyrazolotriazines. ZA991946B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP98104346		1998-03-11

Publications (1)

Publication Number	Publication Date
ZA991946B true ZA991946B (en)	1999-09-13

Family

ID=8231568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9901946A ZA991946B (en)	1998-03-11	1999-03-10	Pyrazolopyrimidines and pyrazolotriazines.

Country Status (33)

Country	Link
US (1)	US6194410B1 (xx)
EP (1)	EP0941994B1 (xx)
JP (1)	JP3231288B2 (xx)
KR (1)	KR100313181B1 (xx)
CN (1)	CN1118468C (xx)
AR (1)	AR016453A1 (xx)
AT (1)	ATE240332T1 (xx)
AU (1)	AU752408B2 (xx)
BR (1)	BR9901095A (xx)
CA (1)	CA2265095C (xx)
CZ (1)	CZ291514B6 (xx)
DE (1)	DE69907784T2 (xx)
DK (1)	DK0941994T3 (xx)
ES (1)	ES2198095T3 (xx)
HR (1)	HRP990077B1 (xx)
HU (1)	HUP9900589A1 (xx)
ID (1)	ID23575A (xx)
IL (1)	IL128869A (xx)
MA (1)	MA26612A1 (xx)
MY (1)	MY119536A (xx)
NO (1)	NO312297B1 (xx)
NZ (1)	NZ334526A (xx)
PE (1)	PE20000337A1 (xx)
PL (1)	PL331875A1 (xx)
PT (1)	PT941994E (xx)
RU (1)	RU2218340C2 (xx)
SG (1)	SG78336A1 (xx)
SI (1)	SI0941994T1 (xx)
TR (1)	TR199900531A2 (xx)
TW (1)	TW585865B (xx)
UY (1)	UY25419A1 (xx)
YU (1)	YU12099A (xx)
ZA (1)	ZA991946B (xx)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000059907A2 (en)	1999-04-06	2000-10-12	Du Pont Pharmaceuticals Company	Pyrazolotriazines as crf antagonists
DE19956791A1 (de)	1999-11-25	2001-05-31	Merck Patent Gmbh	Neue Sulfonyloxazolamine
PE20020394A1 (es)	2000-08-18	2002-06-21	Agouron Pharma	Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
DE60218434T2 (de) *	2001-03-13	2007-11-08	Bristol-Myers Squibb Pharma Co.	4-(2-BUTYLAMINO)-2,7-DIMETHYL-8-(2-METHYL-6-METHOXYPYRID-3-YL) PYRAZOLO- 1,5-Aö-1,3,5-TRIAZIN, SEINE ENANTIOMEREN UND PHARMAZEUTISCH ANNEHMBARE SALZE ALS CORTICOTROPIN-RELEASING-FACTOR-REZEPTOR-LIGANDEN
MXPA03011244A (es)	2001-06-07	2004-02-27	Hoffmann La Roche	Nuevos derivados de indol con afinidad por el receptor 5-ht6.
CA2450245A1 (en)	2001-06-15	2002-12-27	F. Hoffmann-La Roche Ag	4-piperazinylindole derivatives with 5-ht6 receptor affinity
EP1414442A1 (en) *	2001-08-07	2004-05-06	Smithkline Beecham Plc	3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders
IL162243A0 (en) *	2001-12-20	2005-11-20	Wyeth Corp	Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
US6642381B2 (en) *	2001-12-27	2003-11-04	Hoffman-La Roche Inc.	Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitors
GB0202679D0 (en) *	2002-02-05	2002-03-20	Glaxo Group Ltd	Novel compounds
UA78999C2 (en) *	2002-06-04	2007-05-10	Wyeth Corp	1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
US6875771B2 (en)	2002-07-26	2005-04-05	Bristol-Myers Squibb Company	Pyridopyrimidine derivatives as 5-HT6 antagonists
US7196078B2 (en) *	2002-09-04	2007-03-27	Schering Corpoartion	Trisubstituted and tetrasubstituted pyrazolopyrimidines as cyclin dependent kinase inhibitors
PL224879B1 (pl) *	2002-09-04	2017-02-28	Pharmacopeia Drug Discovery Inc	Pirazolo [1,5-a] pirymidynowy związek, jego zastosowanie do wytwarzania leku oraz zawierająca go farmaceutyczna kompozycja
US7329658B2 (en) *	2003-02-06	2008-02-12	Pfizer Inc	Cannabinoid receptor ligands and uses thereof
CN100482662C (zh) *	2003-02-14	2009-04-29	惠氏公司	作为5-羟基色胺-6配体的杂环基-3-磺酰基氮杂吲哚或-氮杂吲唑衍生物
KR20050115252A (ko)	2003-02-28	2005-12-07	데이진 화-마 가부시키가이샤	피라졸로[1,5-ａ]피리미딘 유도체
GB0305559D0 (en) *	2003-03-11	2003-04-16	Teijin Ltd	Compounds
US7585881B2 (en) *	2004-02-18	2009-09-08	Astrazeneca Ab	Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
US20080287405A1 (en) *	2004-05-14	2008-11-20	Thannickal Victor J	Compositions and Methods Relating to Protein Kinase Inhibitors
MX337817B (es) *	2004-11-04	2011-11-04	Vertex Pharma	Pirazolo [1,5-a] pirimidinas de utilidad como inhibidores de proteina quinasas.
RU2390523C2 (ru) *	2005-10-21	2010-05-27	Мицубиси Танабе Фарма Корпорейшн	ПРОИЗВОДНОЕ ПИРАЗОЛ[1,5-a]ПИРИМИДИНА
RU2330854C2 (ru) *	2006-03-15	2008-08-10	Государственное образовательное учреждение высшего профессионального образования "Пермская государственная фармацевтическая академия Федерального агентства по здравоохранению и социальному развитию" (ГОУВПО "ПГФА Росздрава")	Способ получения конденсированных гем-диметилзамещенных амино-1,3,5-триазинов
JP5584626B2 (ja) *	2008-01-24	2014-09-03	アンドレイ・アレクサンドロビッチ・イワシェンコ	２−アルキルアミノ−３−（アリールスルホニル）−シクロアルキル［ｅ又はｄ］ピラゾロ［１，５−ａ］ピリミジン−セロトニン５−ＨＴ６受容体アンタゴニスト、その調製の方法及び使用
RU2369600C1 (ru)	2008-01-24	2009-10-10	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 4-СУЛЬФОНИЛ-ПИРАЗОЛЫ И 3-СУЛЬФОНИЛ-ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ5-HT6 РЕЦЕПТОРОВ, АКТИВНЫЙ КОМПОНЕНТ, ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ЛЕКАРСТВЕННОЕ СРЕДСТВО И СПОСОБЫ ИХ ПОЛУЧЕНИЯ
EP2248817B1 (en) *	2008-01-24	2015-01-07	Alla Chem, LLC.	Substituted 2-amino-3-sulfonyl-pyrazolo[1,5-a] pyrimidines/antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof
EA017818B1 (ru) *	2008-01-24	2013-03-29	Андрей Александрович ИВАЩЕНКО	ЗАМЕЩЕННЫЕ ЦИКЛОАЛКАНО[e ИЛИ d]ПИРАЗОЛО[1,5-a]ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-НТРЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
RU2384581C2 (ru)	2008-05-07	2010-03-20	Андрей Александрович Иващенко	ЗАМЕЩЕННЫЕ 2-АМИНО-3-СУЛЬФОНИЛ-ТЕТРАГИДРО-ПИРАЗОЛО[1,5-a]ПИРИДО-ПИРИМИДИНЫ - АНТАГОНИСТЫ СЕРОТОНИНОВЫХ 5-HT6 РЕЦЕПТОРОВ, СПОСОБЫ ИХ ПОЛУЧЕНИЯ И ПРИМЕНЕНИЯ
CA2755968C (en)	2008-10-06	2019-03-19	Andrey Alexandrovich Ivashchenko	Substituted 3-arylsulfonyl-pyrazolo[1,5-a]pyrimidines, serotonin 5-ht6 receptor antagonists and methods for the production and use thereof
US20120165304A1 (en) *	2008-11-27	2012-06-28	Boehringer Ingelheim International Gmbh	6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them
GB0908394D0 (en)	2009-05-15	2009-06-24	Univ Leuven Kath	Novel viral replication inhibitors
GB0913636D0 (en)	2009-08-05	2009-09-16	Univ Leuven Kath	Novel viral replication inhibitors
BR112013011737A2 (pt)	2010-11-15	2016-08-09	Univ Leuven Kath	composto, uso de um composto composição farmacêutica, e, método de tratamento ou prevenção de uma infecção por hiv
RU2443697C1 (ru)	2010-12-21	2012-02-27	Александр Васильевич Иващенко	Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения
UA113186C2 (xx)	2011-09-30	2016-12-26		Макроциклічні інгібітори lrrk2 кінази
HUE038786T2 (hu) *	2012-03-09	2018-11-28	Lexicon Pharmaceuticals Inc	Pirazolo[1,5-a]pirimidin-alapú vegyületek, ezeket tartalmazó kompozíciók és eljárások alkalmazásukra
TW201542550A (zh) *	2013-09-06	2015-11-16	Lexicon Pharmaceuticals Inc	吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法
TW201620911A (zh) *	2014-03-17	2016-06-16	雷西肯製藥股份有限公司	銜接子關聯激酶１之抑制劑、包含其之組成物、及其使用方法
DK3194405T3 (en)	2014-09-17	2019-04-15	Oncodesign Sa	MACROCYCLIC LRRK2 KINase INHIBITORS
EP3268000B1 (en)	2015-03-09	2021-08-04	Aurigene Discovery Technologies Limited	Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
WO2017052394A1 (en) *	2015-09-23	2017-03-30	Uniwersytet Jagielloński	Imidazopyridine compounds and their use as 5-ht6 receptor ligands
SG11201803605YA (en)	2015-11-02	2018-05-30	Janssen Pharmaceutica Nv	[1,2,4]TRIAZOLO[1,5-a]PYRIMIDIN-7-YL COMPOUND
US10947242B2 (en)	2016-11-02	2021-03-16	Janssen Pharmaceutica, Nv	[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitors
CA3038916A1 (en)	2016-11-02	2018-05-11	Janssen Pharmaceutica Nv	[1,2,4]triazolo[1,5-a]pyrimidine compounds as pde2 inhibitors
WO2018083101A1 (en)	2016-11-02	2018-05-11	Janssen Pharmaceutica Nv	[1,2,4]triazolo[1,5-a]pyrimidine compounds as pde2 inhibitors
CA3138973A1 (en)	2019-05-05	2020-11-12	Qilu Regor Therapeutics Inc.	Cdk inhibitors
CN112142744A (zh) *	2019-06-28	2020-12-29	上海瑛派药业有限公司	取代的稠合杂芳双环化合物作为激酶抑制剂及其应用
JP7744350B2 (ja)	2020-01-13	2025-09-25	バージアナリティクス，インコーポレイテッド	置換ピラゾロ－ピリミジンおよびその使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3907799A (en) *	1971-08-16	1975-09-23	Icn Pharmaceuticals	Xanthine oxidase inhibitors
EP0368897A1 (en)	1987-07-31	1990-05-23	E.I. Du Pont De Nemours And Company	Herbicidal sulfonamides
US4921527A (en) *	1987-07-31	1990-05-01	E. I. Du Pont De Nemours And Company	Herbicidal sulfonamides
DE3825043A1 (de)	1988-07-20	1990-02-15	Schering Ag	3-methylsulfonyl-pyrazolo(1,5-a)pyrimidin-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider, pflanzenwuchsregulierender und fungizider wirkung
US5571813A (en) *	1993-06-10	1996-11-05	Beiersdorf-Lilly Gmbh	Fused pyrimidine compounds and their use as pharmaceuticals
AU7001396A (en)	1995-09-22	1997-04-09	Takeda Chemical Industries Ltd.	Triazole compounds, their production and use
DZ2376A1 (fr)	1996-12-19	2002-12-28	Smithkline Beecham Plc	Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
EP0946551A2 (en)	1996-12-19	1999-10-06	Smithkline Beecham Plc	N-piperazin-1-ylphenyl-benzamide derivatives
EP0994862B1 (en)	1997-07-11	2005-06-01	SmithKline Beecham plc	Sulphonamide derivatives being 5-ht6 receptor antagonists and process for their preparation

1999
- 1999-02-24 US US09/256,927 patent/US6194410B1/en not_active Expired - Fee Related
- 1999-03-03 DE DE69907784T patent/DE69907784T2/de not_active Expired - Fee Related
- 1999-03-03 EP EP99102872A patent/EP0941994B1/en not_active Expired - Lifetime
- 1999-03-03 PT PT99102872T patent/PT941994E/pt unknown
- 1999-03-03 DK DK99102872T patent/DK0941994T3/da active
- 1999-03-03 AT AT99102872T patent/ATE240332T1/de not_active IP Right Cessation
- 1999-03-03 ES ES99102872T patent/ES2198095T3/es not_active Expired - Lifetime
- 1999-03-03 SI SI9930320T patent/SI0941994T1/xx unknown
- 1999-03-08 NZ NZ334526A patent/NZ334526A/xx unknown
- 1999-03-08 IL IL12886999A patent/IL128869A/xx not_active IP Right Cessation
- 1999-03-08 PE PE1999000183A patent/PE20000337A1/es not_active Application Discontinuation
- 1999-03-08 YU YU12099A patent/YU12099A/sh unknown
- 1999-03-08 CA CA002265095A patent/CA2265095C/en not_active Expired - Fee Related
- 1999-03-08 MA MA25485A patent/MA26612A1/fr unknown
- 1999-03-09 AR ARP990100990A patent/AR016453A1/es unknown
- 1999-03-09 MY MYPI99000853A patent/MY119536A/en unknown
- 1999-03-09 UY UY25419A patent/UY25419A1/es unknown
- 1999-03-09 SG SG1999001080A patent/SG78336A1/en unknown
- 1999-03-09 JP JP06114999A patent/JP3231288B2/ja not_active Expired - Fee Related
- 1999-03-10 CZ CZ1999825A patent/CZ291514B6/cs not_active IP Right Cessation
- 1999-03-10 RU RU99105137/04A patent/RU2218340C2/ru active
- 1999-03-10 ID IDP990198D patent/ID23575A/id unknown
- 1999-03-10 KR KR1019990007881A patent/KR100313181B1/ko not_active Expired - Fee Related
- 1999-03-10 TW TW088103692A patent/TW585865B/zh not_active IP Right Cessation
- 1999-03-10 ZA ZA9901946A patent/ZA991946B/xx unknown
- 1999-03-10 BR BR9901095-0A patent/BR9901095A/pt not_active Application Discontinuation
- 1999-03-10 HU HU9900589A patent/HUP9900589A1/hu not_active Application Discontinuation
- 1999-03-10 PL PL99331875A patent/PL331875A1/xx unknown
- 1999-03-10 NO NO19991150A patent/NO312297B1/no unknown
- 1999-03-11 AU AU20383/99A patent/AU752408B2/en not_active Ceased
- 1999-03-11 TR TR1999/00531A patent/TR199900531A2/xx unknown
- 1999-03-11 HR HR990077A patent/HRP990077B1/xx not_active IP Right Cessation
- 1999-03-11 CN CN99105964A patent/CN1118468C/zh not_active Expired - Fee Related

Also Published As

Publication number	Publication date
JP2000186090A (ja)	2000-07-04
CZ291514B6 (cs)	2003-03-12
AU752408B2 (en)	2002-09-19
IL128869A (en)	2003-09-17
BR9901095A (pt)	2000-05-02
PT941994E (pt)	2003-09-30
YU12099A (sh)	2000-10-30
UY25419A1 (es)	2001-11-30
KR100313181B1 (ko)	2001-11-05
SI0941994T1 (en)	2003-10-31
AU2038399A (en)	1999-09-23
SG78336A1 (en)	2001-02-20
CA2265095C (en)	2008-07-22
DE69907784D1 (de)	2003-06-18
ATE240332T1 (de)	2003-05-15
CA2265095A1 (en)	1999-09-11
AR016453A1 (es)	2001-07-04
HUP9900589A1 (hu)	2000-03-28
PL331875A1 (en)	1999-09-13
IL128869A0 (en)	2000-01-31
NO312297B1 (no)	2002-04-22
EP0941994A1 (en)	1999-09-15
CN1118468C (zh)	2003-08-20
HK1023343A1 (en)	2000-09-08
DE69907784T2 (de)	2004-03-25
MA26612A1 (fr)	2004-12-20
ID23575A (id)	2000-05-04
KR19990077741A (ko)	1999-10-25
TR199900531A3 (tr)	1999-10-21
NZ334526A (en)	2000-07-28
RU2218340C2 (ru)	2003-12-10
EP0941994B1 (en)	2003-05-14
TW585865B (en)	2004-05-01
HU9900589D0 (en)	1999-05-28
HRP990077A2 (en)	2000-02-29
ES2198095T3 (es)	2004-01-16
NO991150L (no)	1999-09-13
HRP990077B1 (en)	2003-08-31
PE20000337A1 (es)	2000-05-13
CN1236780A (zh)	1999-12-01
MY119536A (en)	2005-06-30
US6194410B1 (en)	2001-02-27
JP3231288B2 (ja)	2001-11-19
TR199900531A2 (xx)	1999-10-21
NO991150D0 (no)	1999-03-10
CZ82599A3 (cs)	1999-09-15
DK0941994T3 (da)	2003-09-08

Publication	Publication Date	Title
ZA991946B (en)	1999-09-13	Pyrazolopyrimidines and pyrazolotriazines.
ZA991951B (en)	1999-08-16	Compound and its use.
HU9903361D0 (en)	1999-12-28	Filter-device with collecting-vessel and with heating-device
DE69927412D1 (en)	2006-02-02	Phosphitadditive in polyolefinen
ZA996185B (en)	2000-04-10	Sulfanylsilanes.
ZA9710429B (en)	1998-06-10	Broad-spectrumδ-endotoxins.
ZA200005136B (en)	2001-03-02	Dihydropyrimides.
ZA979199B (en)	1998-05-11	Aminothiophenecarboxamides.
ZA976168B (en)	1998-02-02	3-Ureido-pyridofurans and -pyridothiophenes.
ZA977206B (en)	1999-11-12	Arylalkanoylpyridazines.
ZA978304B (en)	1998-03-24	3-alkyl-3-phenyl-piperidines.
ZA981926B (en)	1999-09-06	Detergent--package combination.
ZA992443B (en)	1999-10-01	Hydroxy-methyl-hexanones.
ZA99849B (en)	2000-08-03	Lipid mixtures and their use.
ZA993123B (en)	1999-11-08	Trisresorcinyltriazines.
ZA995325B (en)	2000-02-22	Methylcyclotetradec-5-en-1-ones.
ZA97572B (en)	1997-08-04	1-pyrazol-3-ylethyl-4-indol-3-ylpiperidines.
ZA991575B (en)	1999-08-27	N-sulphonyl and N-sulphinyl phenylglycinamide.
ZA983705B (en)	1999-11-01	Pregnan-3-ol-20-ones.
ZA971466B (en)	1997-08-28	Endothelin-receptor-antagonists.
ZA976022B (en)	1998-02-02	Cycloalkano-pyridines.
ZA981309B (en)	1999-08-17	4-aminoalkoxy-1H-benzoimidazoles.
ZA971474B (en)	1997-08-28	Endothelin-receptor-antagonists.
ZA975469B (en)	1997-12-22	X14-mannitol.
ZA977142B (en)	1998-02-16	Belt-lock.